Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2069]
News [6417]
Articles [133]
Editorials [5]
Conferences [170]
elearning [10]
Alectinib eclipses crizotinib for ALK positive lung cancer
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Alectinib eclipses crizotinib for ALK positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2017
Results from the APHINITY trial of two HER2 targeted agents with chemo
Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Results from the APHINITY trial of two HER2 targeted agents with chemo ( Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
5 Jun 2017
Treating BRCA breast cancer with PARP inhibition
Dr Mika Sovak - AstraZeneca, Cambridge, UK
Treating BRCA breast cancer with PARP inhibition ( Dr Mika Sovak - AstraZeneca, Cambridge, UK )
4 Jun 2017
Nivolumab and ipilimumab for metastatic sarcoma
Dr Sandra D'Angelo - Memorial Sloan Kettering Cancer Center, New York, USA
Nivolumab and ipilimumab for metastatic sarcoma ( Dr Sandra D'Angelo - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
Dose escalation results of ceritinib and nivolumab for ALK NSCLC
Dr Enriqueta Felip - Vall d’Hebron University Hospital, Barcelona, Spain
Dose escalation results of ceritinib and nivolumab for ALK NSCLC ( Dr Enriqueta Felip - Vall d’Hebron University Hospital, Barcelona, Spain )
4 Jun 2017
Phase III results of olaparib for BRCA breast cancer
Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA
Phase III results of olaparib for BRCA breast cancer ( Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
Tivantinib as second line therapy for high-MET HCC
Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy
Tivantinib as second line therapy for high-MET HCC ( Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy )
4 Jun 2017
3 or 6 months adjuvant oxaliplatin for colorectal cancer
Dr Tim Iveson - University Hospital Southampton, Salisbury, UK
3 or 6 months adjuvant oxaliplatin for colorectal cancer ( Dr Tim Iveson - University Hospital Southampton, Salisbury, UK )
4 Jun 2017
No link between pregnancy and breast cancer relapse
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
No link between pregnancy and breast cancer relapse ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
4 Jun 2017
Pooled analysis of avelumab for metastatic urothelial carcinoma
Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
Pooled analysis of avelumab for metastatic urothelial carcinoma ( Dr Andrea Apolo - National Cancer Institute, Bethesda, USA )
3 Jun 2017
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers
Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers ( Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA )
3 Jun 2017
Routine genomic testing is feasible, but only a subset of patients benefit
Dr Olivier Trédan - Centre Léon Bérard, Lyon, France
Routine genomic testing is feasible, but only a subset of patients benefit ( Dr Olivier Trédan - Centre Léon Bérard, Lyon, France )
3 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation